Literature DB >> 22655489

The effects on cordal and leaflet stiffness of severe apical, posterior, and outward papillary displacement in advanced ventricular mechanism heart failure and mitral insufficiency.

Robert W M Frater1.   

Abstract

BACKGROUND AND AIM OF THE STUDY: During the normal opening and closing of the mitral valve there is a finely tuned interaction between the changing ventricular dimensions and fluid pressures, the movement of papillary muscles apically, posteriorly and apart during diastole and in the opposite direction during systole, interactions between leaflets and their controlling cords, and the fluid dynamic forces being exerted on them. The main rough zone cords and the smooth zone of the anterior leaflet are under maximum tension in systole, but retain some tension throughout the cycle. The free edge cords and the rough zone of the leaflets can have no or minimal tension during diastole, and much less tension than the main rough zone cords and the smooth zone in systole. The variability of the form and distribution of rough zone cords influences the flexibility of the rough zone. The net effect of this interaction is a valve that opens rapidly for unobstructed forward flow, and closes at the end of the cycle with minimal leakage. The apical displacement of, usually, the right inferior papillary muscle as a result of ischemic ventricular disease pulls the leaflets into separation because the origins of cords supporting the anterior and posterior leaflets arise specifically from the anterior and posterior sides of each papillary muscle. Myocardial ischemia producing apical papillary displacement can be associated with heart failure and mitral insufficiency. Annuloplasty reducing the annulus to less than the normal systolic dimension can be effective in eliminating both insufficiency and heart failure when the papillary displacement is dominantly apical. In more severe cases of heart failure and mitral insufficiency, the mid-ventricular dimensions increase to a more severe degree, and both papillary muscles are displaced outwards and posteriorly. METHODS AND
RESULTS: Static in vitro experiments performed on three human and nine pig hearts showed that the outward papillary displacements increased the tension on first-order cords, rendering the anterior leaflet and the central scallop of the posterior leaflet stiff. The addition of posterior displacement caused the anterior leaflet to become directed at an angle to the displaced papillary muscles, and the scallops of the posterior leaflet to be perpendicularly splayed around the posterior left ventricular wall, such that the valve no longer opened or closed correctly.
CONCLUSION: The valve no longer opens or closes properly, and annuloplasty is no longer of use in restoring valve function.

Entities:  

Mesh:

Year:  2011        PMID: 22655489

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  4 in total

Review 1.  Benefits of submitral procedures for ischemic mitral regurgitation.

Authors:  Satoru Wakasa; Yoshiro Matsui
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-07-15

2.  Surgical strategy for ischemic mitral regurgitation adopting subvalvular and ventricular procedures.

Authors:  Satoru Wakasa; Yasushige Shingu; Tomonori Ooka; Hiroki Katoh; Tsuyoshi Tachibana; Yoshiro Matsui
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-02-16       Impact factor: 1.520

3.  Mitral Leaflet Changes Following Myocardial Infarction: Clinical Evidence for Maladaptive Valvular Remodeling.

Authors:  Jonathan Beaudoin; Jacob P Dal-Bianco; Elena Aikawa; Joyce Bischoff; J Luis Guerrero; Suzanne Sullivan; Philipp Emanuel Bartko; Mark D Handschumacher; Dae-Hee Kim; Jill Wylie-Sears; Jacob Aaron; Robert A Levine
Journal:  Circ Cardiovasc Imaging       Date:  2017-11       Impact factor: 7.792

4.  The extent of papillary muscle approximation affects mortality and durability of mitral valve repair for ischemic mitral regurgitation.

Authors:  Satoru Wakasa; Suguru Kubota; Yasushige Shingu; Tomonori Ooka; Tsuyoshi Tachibana; Yoshiro Matsui
Journal:  J Cardiothorac Surg       Date:  2014-06-03       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.